CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Multiplicom is developing a business plan for a multiplex miRNA test kit aimed at improving diagnosis and treatment for triple-negative breast cancer. The project includes selecting relevant miRNAs, conducting clinical validation, and analyzing market opportunities.
Multiplicom will draft a business plan that is composed of the following parts:(i)selection of miRNAs for which there is substantial scientific evidence that such may be important for the diagnosis, treatment and/or prognosis of
triple-negative breast cancer (“TNBC”) patients;(ii)perform a thorough analysis of the intellectual property on the selected miRNAs;(iii)start in-licensing negotiations with licensors regarding relevant intellectual property(iv)select a
suitable quantitative multiplex mi…
MULTIPLICOM NV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
